Christopher Galletta - Controller and Principal Accounting Officer at Trevi Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Controller and Principal Accounting Officer
Issuer Symbol
TRVI on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Galletta since 05 Jan 2025

Holdings reported by Christopher Galletta for Trevi Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 26,095 $13,334 $0.5110 02 Dec 2025 Direct
Stock Option (right to buy) 15,775 02 Dec 2025 Direct Common Stock
Performance Stock Option (right to buy) 13,110 31 May 2025 Direct Common Stock

Transactions reported by Christopher Galletta for Trevi Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.